AustinPx was founded to help developers realize the full potential of their drug candidates. There are many obstacles to bringing a drug to market, including poor bioavailability and accelerated timelines. That’s where we come in. Our client-centric approach is designed to simplify the complexity of outsourcing and our team of formulation, analytical and manufacturing experts work with you to overcome challenges and identify opportunities to do more, faster.
As the inventors of the KinetiSol® Technology - a next generation amorphous solid dispersion (ASD) technology for poorly soluble APIs - we look to disrupt the ASD industry with its smaller footprint, broader design space, and greener processing solution.
Our Name is our Brand
AustinPx represents where we come from and what we do. Px stands for Pharmaceutics. To our core, we are a pharmaceutics company. Our approach is data-driven and technology-nonbiased, which means our formulation strategy for each drug is based on the unique physiochemical characteristics of the molecule and the client's goals. And for poorly soluble compounds, we have one of the most powerful tools available in KinetiSol, a next generation amorphous dispersion technology.
From poor solubility to accelerated timelines, drug development is inherently complex. Effective communication and flexible processes can simplify your path to the market. That is why AustinPx has developed a client-centric approach to contract development and manufacturing services. We are driven by our client’s success and intentional about differentiating ourselves through flexibility and responsiveness, and consultative, unbiased, solutions-driven development services.